A Study in Patients With Advanced Breast Cancer

Clinical trial NCT04942054 · TERMINATED

Trial details

NCT number: NCT04942054
Sponsor: Sun Pharma Advanced Research Company Limited
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-negative Breast Cancer Advanced Breast Cancer Hormone Receptor-positive Breast Cancer

Start date: 2022-05-20
Primary completion: 2023-02-28
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.